Optimizing cell culture and analysis using LC-MS
5 Feb 2025
The biopharmaceutical market is rapidly growing with new therapeutics and biosimilars. Contributing to this growth is the development of therapeutic monoclonal antibodies to treat a variety of serious diseases. The increased interest in biologics has resulted in significant growth in the cell cultures market. Ensuring that the cultural media mix is optimal for cell growth is vital to drug development and the quality of the final product. Hear how technological advancements like LC-MS improve analysis accuracy, aid in the production of monoclonal antibodies and ensure quality in biosimilars and stem cell research.
About the company
Shimadzu Corporation
Shimadzu Corporation was founded in Kyoto, Japan in 1875 and has been supplying cutting-edge analytical and measuring instruments for a broad range of applications for over 140 years. Key markets include pharmaceuticals, life sciences, food & beverages, chemicals, petrochemicals, environmental, material science, and forensics/toxicology. Products include chromatographs (HPLC/UHPLC/SFC, GC), mass spectrometers (GC-MS/MS, LC-MS/MS, MALDI, ICP-MS), spectrophotometers (FT-IR, Fluorescence, UV-VIS-NIR), atomic spectrometers (AA, ICP), X-ray spectrometers (ED-XRF, XRD, XRF), thermal analyzers, Total Organic Carbon (TOC) analyzers, particle size analyzers, material testing machines, and balances, etc.
